BioCryst's new website for its HAE unbranded campaign encourages patients to take charge of treatment decisions.

BioCryst launch­es aware­ness cam­paign around man­age­ment of rare vas­cu­lar dis­ease

While hered­i­tary an­gioede­ma (HAE) is rare, treat­ment op­tions for the con­di­tion have be­come much more com­mon. So BioCryst Phar­ma­ceu­ti­cals is tak­ing a new an­gle in its re­cent­ly launched HAE aware­ness cam­paign en­cour­ag­ing pa­tients to take con­trol of their dis­ease man­age­ment.

“Hered­i­tary an­gioede­ma (HAE) isn’t the au­thor of your sto­ry — you are … #cHAEngeth­e­p­lan. Not the goal,” the US cam­paign web­site ad­vis­es.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.